Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 06/30/2020

Month EndAs of 06/30/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 23.44 10.27 2.59 18.55 11.89
Fund with Sales Charge (%) (POP) 23.44 10.27 2.59 18.55 11.89
NASDAQ Biotechnology Index (%) 25.36 9.81 2.14 18.43 12.05
S&P 500 Index (%) 7.51 10.73 10.72 13.99 7.49
Quarter EndAs of 06/30/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 23.44 10.27 2.59 18.55 11.89
Fund with Sales Charge (%) (POP) 23.44 10.27 2.59 18.55 11.89
NASDAQ Biotechnology Index (%) 25.36 9.81 2.14 18.43 12.05
S&P 500 Index (%) 7.51 10.73 10.72 13.99 7.49

Calendar Year Returns

2019 2018 2017 2016 2015 2014 2013
Fund without Sales Charge (%) (NAV) 35.35 -15.41 19.32 -16.82 5.89 34.50 69.49
Fund with Sales Charge (%) (POP) 35.35 -15.41 19.32 -16.82 5.89 34.50 69.49
NASDAQ Biotechnology Index (%) 24.41 -9.32 21.06 -21.68 11.42 34.32 65.97
S&P 500 Index (%) 31.49 -4.38 21.83 11.96 1.38 13.69 32.39

Cumulative Total Returns [further-information] As of 06/30/2020

Month EndAs of 06/30/2020 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 13.21 23.44 34.08 13.66 448.08 1,192.90
Fund with Sales Charge (%) (POP) 13.21 23.44 34.08 13.66 448.08 1,192.90
NASDAQ Biotechnology Index (%) 13.49 25.36 32.41 11.20 442.81 1,235.98
S&P 500 Index (%) -3.08 7.51 35.77 66.45 270.31 418.39
Quarter EndAs of 06/30/2020 YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 13.21 23.44 34.08 13.66 448.08 1,192.90
Fund with Sales Charge (%) (POP) 13.21 23.44 34.08 13.66 448.08 1,192.90
NASDAQ Biotechnology Index (%) 13.49 25.36 32.41 11.20 442.81 1,235.98
S&P 500 Index (%) -3.08 7.51 35.77 66.45 270.31 418.39

After-Tax Average Annual Total Returns [further-information] As of 06/30/2020

Month EndAs of 06/30/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 21.01 8.92 1.11 17.05
Fund without Sales Charge (%) (NAV) After Shares Sold 15.24 7.65 1.58 15.37
Fund with Sales Charge (%) (POP) Before Shares Sold 21.01 8.92 1.11 17.05
Fund with Sales Charge (%) (POP) After Shares Sold 15.24 7.65 1.58 15.37
Quarter EndAs of 06/30/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 21.01 8.92 1.11 17.05
Fund without Sales Charge (%) (NAV) After Shares Sold 15.24 7.65 1.58 15.37
Fund with Sales Charge (%) (POP) Before Shares Sold 21.01 8.92 1.11 17.05
Fund with Sales Charge (%) (POP) After Shares Sold 15.24 7.65 1.58 15.37

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 0.72%
Net Expense Ratio [further-information] 0.65%
Max Initial Sales Charge 0.00%
CDSC

Volatility Measures [further-information] As of 06/30/2020 Updated Monthly, based on a 3-year period

Beta 1.03
Sharpe Ratio 0.36
Standard Deviation 23.76

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index